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Jtes 14 presenceC wim dor,bìe hecerozygous PS defecc and A.3 hanìor,.rne.
5-'with PS defecr aìone, t- wirh A3 É;pt;il.;;;;;rd'jl;5;;;5;1
carriers of either defect. VTE had occured.in 7.I%, 28%. S.9oA and
? 9'( ?[ family membe:s. respecuvely. In rhe upper quartile of sEpCR
Ievels, individuals wirh PS defécts preslnted a risk 3-fold higher ro devel-
op WE as compared to those without PS defects. In rhe lówer quartile
of sEPCR levels, the risk for VTE was abour 2-fold hieher rn cariiers as
compared to non-carriers of PS defecrs. Among ,103 individuals fiom AT
deFrcrent families, 8 presented with double herérozygous Af defects and
A3 haplotype, 43 wirh Af defects alone, 9 with AS liaplorype alone and
43 wiah no defect. VTE had occurred tn25oA,33%,5.5%'and I.2oA of
lamily members, respectively. The risk of VTE in cariers of Af was 5-fnlrr hiryha- rc ra--.-^r co non_carriers both in the un^er end in rheu Lc JtyuL
lower quartile of sEPCR ievels. In conclusion, the presenie of AB haplo-
rype and sEPCR plasma levels rnight.rrlodulaie the clinical expression of
thrombophiiia in clorúng inhibicòr deficient paciencs. prospectrve srud-
res are needed. to conhrm rhese tindrnss.
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EFFECI OFAPC RISISTANCEASSOCIATED WITH TACTOR V MUTATIONS ON PTASMA
FIBRIN()TYSIS
Colucci M, Binetti BM, Spiezia L, Gavasso S, Semeraro N, Simioni ?
DeVanment of Biamedical Scíences, Section of General Pathology, University of
Bari; and Universiry-Hosyítal of Padua, Internal Atledicine, Padua, Italy
Faccor V is endowed widr both procoaguiant and ancicoagulant prop-
erries. AIC resiscance caused by homozl)gous FV Leiden niutation hàs
been shown to inhibit fibrinolysis throueÀ rhe enhancement of throm-
bin-mediated accivation of TAII (thrómbn acdvarable fibrinolysis
inhibiror). It is unclear, however, wherher her-erozvqous cariers of ieí-
den mutation or carriers of other FV genotypes àsiociated with ApC
resístance have a defective fibrinolytic àctiviii. We srudied 107 subiects
with different IV genorypes (rable). Sixty-seie.t *ere unrelated asymp-
comatrc subjects wirh or wjrhout Leiden mutation while 40 beloneed Èo
6 families with combined IV mutations. Plasma fibrinolytic caóacirv
was studied by evaluating the lysis time of tjssue facror-inducecjrdoís
exposed ro 25 ng/mJ exogenous t-PA. The assay was performed in the
absence and in the preseÀce 
.of APC (1 microg,rnl; and the tibrinoiyric
respons_e was calcula_red by dre ratio of the rwo lysis cimes (ApC tysis
ratio). Heterozygous Leiden mutaúon was associaied with a sienificànt-
ly reduced AIC iysis ratio borh in uruelared subjects and in me"mbers of
thrombophilic families. Moreover, rhe combina'tion o[ Leiden mutation
wirh type I W deficiency ipseudohomo A?C resistance) made thet n r r r_v o l t (pseuoono ozygous fL l
plasma tocallv unresnonsive ro tl'e Fihrinnlwrie etlecr nr APC mimiclinot,,--'-'--r''"---!,-'-- "" :.."^::^:i"'/:""j:::':"ihe homozygous Leiden mutarron. Neideei the HM haplotype nor rvlr;
I FV deficienry, when presenc in heterozygous form, inÉluenced -ùe
response to APC. Incerestingiy, the two patiènts wicn Leiden plus HM
a.nd 
^the 
pacienc wirh HR2 pfuì rype I deficiency were also refracrory ro the t l"ui rype v t v t
rhe fibrinolytic activiry of APC.'These data inóicace that heterozvíoustn ÍDn t l lt l'U" t h di t r zyq
cariers of the Leiden mutation are resistant to the fibrinolvtic efieit of
APC. This resistance, however is affenr,:fey' h', rho .'s5gn6e of normal:-;----^-,-,. "/ :: Y:i*t"'V;;il1.*di; efiactoriness to AIC of the combiaationsra_cror v as rnolcareo oy srong r f n l,L i
of leiden with either'rVpe I Aeficiency or HR2 haplotype
Table 1. APC lysis ratio in patients with different factor V genotypes
Unrelated subjects Menbers of thronbaphihc fanilies
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TISSUE FACIOR A.603G GENOWPE ASSOEIATES WITH CAROTID INTIMA,MEDIA
TIiICKNESS IN SUEJECTS UNDERG()ING CARDIOVASCUTAR RISK PREVENTION
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.Tissue factor (fI), key initiator of coagulation, is also ascribed a non-
haemostatic function in ìnflammation, cé11 rnigration and proliferation,
suggesting a role of TF not onJy in thrombosiibut also in àtherosclero-
sis developmenr. Po-ymorphisms in the TF gene promorer have been
shown ro modulare the expression of T! and thereby pocentially also its
invoivement in atherosclerosis and individual prediífosition tó athero-
scierrtic disease. Hence. rhis study was aimed at investigating associa-
trons becween TF promoter polymorpfusms and carotid'intiria-media
*rickness (lMl, a well-establs6ed surrogate marker of atheroscleroric
disease. To this end, the TF A-603G poiyÀorphism was analysed in 316
subjects enrolled in a primary and setoódary cardiovascular úsk preven-
tion programme, wirh measurements of carorid IMT by B-mode ulua-
sound. A.lso, the TI Ins-1208De1 polymorphism was iívestieated in a
limited number of subjects, which c'onfirired the previousltireported
complete concordance'berween the -6034 and -12OBDel aielel. The
suhjects were aged 60.2x8.4 years,807o were male, andTB1A were
undergoing secoÀdary preventjón with a hisro*ry of corona ry, 
.cerebrovas-cular, or peripheral atherosclerottc disease. Borh mean and maximum
carotid iMT (measured at the common carotid artery, carotid bifurcation,
and intemal carotid artery) differed significandy àccorcling to A-603G
genot:ypel being highest ií -603A/A (nJ93), intermediate in"afC qn=tOt1
and lowest in C/C (n=62) (mean IMT: A/A 7.31x0.36 mm, A./G
!?ZtQ.?9mm, C/G 1.19x0.32 mm; max IMT: NA2.36I0.BB mm, A./G
2.26+0.85 mm,2"05t0.B8 mm; boú,V<0.05; adjusted for age, gender, and
sratin rreacment). In summary, a significanr associadon belvàen TI pro-
mocer genotype and carorid-lMTivas observed, perhaps mediated via
alterations of TI expression levels in the círculation or within the carotid
vessel wal1. These lindings supporr the hypothesi.s that TI plavs a role
in the arherosclerorìc proèess, bèyond its #eI-known role in híemosta-
sis and thrombosis, thus funher-implicaring TI noc onlv in tluombotic
complications of atheroscleroric disàase, bu"t also in placjue progression.
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Hyperhomocysteinemia is a well known independenr risk facror for
atherothrombotic diseases. Mjld hyperhomocvsteinemia mav result
trom both acquired and genetìc ínflúences. Sevóral polvmomfír-, ,r.
suspected_co be associareà with hyperhomocysreinemia, bud often date
are iimited and inconsisrenr due to the lack of iobust studíed populations
and/or of dara on rhe possible inceracúon amone SNps in eànés codins
molecules infiuencing'medrionine metabolism. Éish-rhroíshpur senol
ryping technologies, suclì as chat provided b"v the Ò.io.r.'.trU
SNPStream from Beckman Coulter (4,600-890,00(j senorypes/dav) are
now available and an appropriate definirion of SNPs tó be inalysed could
represent a strong resource in order to quicklv and definirivelv define the
roie of genetic 
'iír rr.ro" o" air;;;;rlW;;";;É;A;;ÉpI.. pCzuoligonucledotide extension assay wirh the Cenomelab SNPStream plat-
form to derecc SNPs in genes códing molecules invoived in the methio-
nine metabolism. We selected SNPs"based on rheir putative function and
frequency in candidare genes exrracted from PubMed resources. The
annotation of each SNf and its frequency in Caucasian populations was
assessed ín several databases. We éelectèd 22 SNps: Z in MTHIDI. 5 in
Nry.ryf, 
-3 
rn P_O,\1, 2 in PON2, 5 in TCMI, 4 in AHC! Z in MTRR, 5 in
!ryÀ4I^3.i1CC?2, 5 in MTHI& ó in MT\ 3 in TYMS, 3 in cSHMTl,5.in RICf 7-in CBS, 2 in BHMT2 gene. They were analyzed in 6 pan-
els of 12 SNPs each according ro tÉeir nrrcleltide srrl--';..'-;^- /4 i-r 1
c A 1 cc, r c,t . 
"J z 
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an4 in 3 p anels' 1 I / L2 designed"SNls worked: theíefo ró, we
could analyze 69 outóî72 (96%) SNPsiAs concems 3 SNps, C677T'and
AI'298C in MTHFR gene and ,\2756C in MTR gene, we compared data
obcai,red wirh an eleétronic microchip rechnoloív (Nanopenl in 2BB sub-
j e cts. We sho we d a 9 B.S 9 o.;;.;'àJ* 
''itÀ ìh? ù; ;;-."h"; il;; ?h.
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